Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...